These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 37709978)
1. Identification of immune-related signature with prognosis in children with stage 4 and 4S neuroblastoma. Cao L; Liu Q; Ma Y; Wang S Clin Transl Oncol; 2024 Apr; 26(4):905-916. PubMed ID: 37709978 [TBL] [Abstract][Full Text] [Related]
2. Integrative analysis with machine learning identifies diagnostic and prognostic signatures in neuroblastoma based on differentially DNA methylated enhancers between INSS stage 4 and 4S neuroblastoma. Li S; Mi T; Jin L; Liu Y; Zhang Z; Wang J; Wu X; Ren C; Wang Z; Kong X; Liu J; Luo J; He D J Cancer Res Clin Oncol; 2024 Mar; 150(3):148. PubMed ID: 38512513 [TBL] [Abstract][Full Text] [Related]
3. Identification of a ferroptosis-related gene signature for the prognosis of pediatric neuroblastoma. Lin X; Shao K; Lin Z; Liang Q; Li X; Chen H; Wu J Transl Cancer Res; 2024 Jul; 13(7):3678-3694. PubMed ID: 39145053 [TBL] [Abstract][Full Text] [Related]
4. Comparison of Stage 4 and Stage 4s Neuroblastoma Identifies Autophagy-Related Gene and LncRNA Signatures Associated With Prognosis. Meng X; Li H; Fang E; Feng J; Zhao X Front Oncol; 2020; 10():1411. PubMed ID: 32974147 [No Abstract] [Full Text] [Related]
5. Combined analysis of RNA-sequence and microarray data reveals effective metabolism-based prognostic signature for neuroblastoma. Meng X; Feng C; Fang E; Feng J; Zhao X J Cell Mol Med; 2020 Sep; 24(18):10367-10381. PubMed ID: 32683778 [TBL] [Abstract][Full Text] [Related]
6. Identification of prognostic long noncoding RNAs associated with spontaneous regression of neuroblastoma. Meng X; Fang E; Zhao X; Feng J Cancer Med; 2020 Jun; 9(11):3800-3815. PubMed ID: 32216054 [TBL] [Abstract][Full Text] [Related]
7. A signature of 29 immune-related genes pairs to predict prognosis in patients with neuroblastoma. Song J; Zhao Q; Xu Y; Zhu L Int Immunopharmacol; 2020 Nov; 88():106994. PubMed ID: 33182060 [TBL] [Abstract][Full Text] [Related]
8. Identification of hub genes and their correlation with infiltration of immune cells in Chen J; Sun M; Chen C; Jiang B; Fang Y Front Immunol; 2022; 13():1016683. PubMed ID: 36311753 [TBL] [Abstract][Full Text] [Related]
9. Integration of clinical characteristics and molecular signatures of the tumor microenvironment to predict the prognosis of neuroblastoma. Cheng H; Zhang L; Yang S; Ren Q; Chang S; Jin Y; Mou W; Qin H; Yang W; Zhang X; Zhang W; Wang H J Mol Med (Berl); 2023 Nov; 101(11):1421-1436. PubMed ID: 37712965 [TBL] [Abstract][Full Text] [Related]
10. Development and validation of a novel stemness-related prognostic model for neuroblastoma using integrated machine learning and bioinformatics analyses. Xia Y; Wang C; Li X; Gao M; Hogg HDJ; Tunthanathip T; Hulsen T; Tian X; Zhao Q Transl Pediatr; 2024 Jan; 13(1):91-109. PubMed ID: 38323183 [TBL] [Abstract][Full Text] [Related]
11. A novel cuproptosis-related subtypes and gene signature associates with immunophenotype and predicts prognosis accurately in neuroblastoma. Tian XM; Xiang B; Yu YH; Li Q; Zhang ZX; Zhanghuang C; Jin LM; Wang JK; Mi T; Chen ML; Liu F; Wei GH Front Immunol; 2022; 13():999849. PubMed ID: 36211401 [TBL] [Abstract][Full Text] [Related]
12. Tumor dormancy is closely related to prognosis prediction and tumor immunity in neuroblastoma. Tian X; Cao F; Li X; He Y; Xia Y; Chen L; Zhao Q Transl Pediatr; 2023 Mar; 12(3):445-461. PubMed ID: 37035400 [TBL] [Abstract][Full Text] [Related]
13. Construction of a redox-related gene signature for overall survival prediction and immune infiltration in non-small-cell lung cancer. Miao TW; Yang DQ; Gao LJ; Yin J; Zhu Q; Liu J; He YQ; Chen X Front Mol Biosci; 2022; 9():942402. PubMed ID: 36052170 [No Abstract] [Full Text] [Related]
14. Identification of Potential Prognostic Genes for Neuroblastoma. Zhong X; Liu Y; Liu H; Zhang Y; Wang L; Zhang H Front Genet; 2018; 9():589. PubMed ID: 30555514 [No Abstract] [Full Text] [Related]
15. Construction of a novel anoikis-related prognostic model and analysis of its correlation with infiltration of immune cells in neuroblastoma. Chen J; Sun M; Chen C; Kang M; Qian B; Sun J; Ma X; Zhou J; Huang L; Jiang B; Fang Y Front Immunol; 2023; 14():1135617. PubMed ID: 37081871 [TBL] [Abstract][Full Text] [Related]
16. Identification and validation of a novel signature as a diagnostic and prognostic biomarker in colorectal cancer. Wang D; Liufu J; Yang Q; Dai S; Wang J; Xie B Biol Direct; 2022 Nov; 17(1):29. PubMed ID: 36319976 [TBL] [Abstract][Full Text] [Related]
17. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets. Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873 [TBL] [Abstract][Full Text] [Related]
18. Construction of a novel choline metabolism-related signature to predict prognosis, immune landscape, and chemotherapy response in colon adenocarcinoma. Liu C; Liu D; Wang F; Liu Y; Xie J; Xie J; Xie Y Front Immunol; 2022; 13():1038927. PubMed ID: 36451813 [TBL] [Abstract][Full Text] [Related]
19. Identification of a Five-Gene Signature Derived From MYCN Amplification and Establishment of a Nomogram for Predicting the Prognosis of Neuroblastoma. Xia Y; Li X; Tian X; Zhao Q Front Mol Biosci; 2021; 8():769661. PubMed ID: 34950701 [No Abstract] [Full Text] [Related]
20. The Landscape of the Tumor Microenvironment in Skin Cutaneous Melanoma Reveals a Prognostic and Immunotherapeutically Relevant Gene Signature. Zhou S; Sun Y; Chen T; Wang J; He J; Lyu J; Shen Y; Chen X; Yang R Front Cell Dev Biol; 2021; 9():739594. PubMed ID: 34660598 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]